Coronary microvascular dysfunction: Phenotype-specific targeted therapies

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine Pub Date : 2025-07-01 DOI:10.1016/j.carrev.2025.06.014

Gianluca Mincione , Matteo Maurina , Alice Benedetti , Mauro Chiarito , Giulio G. Stefanini , Pieter C. Smits , Valeria Paradies

引用次数: 0

Abstract

Coronary microvascular dysfunction has always been a clinical entity that is often underdiagnosed and with limited therapeutic options. In this review, we aim to provide a comprehensive view of the pathology, correlating it with specific syndromic presentations to which it is often linked, and based on these, propose tailored diagnostic and therapeutic strategies.

查看原文本刊更多论文

冠状动脉微血管功能障碍：表型特异性靶向治疗。

冠状动脉微血管功能障碍一直是一个临床实体，往往诊断不足，治疗方案有限。在这篇综述中，我们的目标是提供一个全面的病理视图，将其与特定的综合征表现联系起来，并基于这些，提出量身定制的诊断和治疗策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

3.30

自引率

5.90%

发文量

687

审稿时长

36 days

期刊介绍： Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.